Status:
RECRUITING
3D-PCT Combined With CT-guided Radioactive I-125 Seed Implantation in the Treatment of Head and Neck Tumors
Lead Sponsor:
Peking University Third Hospital
Conditions:
Malignant Tumor of Head and/or Neck
Eligibility:
All Genders
18-80 years
Brief Summary
The purpose of this study is to verify the accuracy, short-term efficacy and side effects of 3D printing coplanar template combined with CT-guided I-125 seeds implantation in the treatment of malignan...
Detailed Description
Iodine-125 seeds Implantation (RISI) for the treatment of tumors, mainly with the help of imaging guidance, the radioactive I-125 seeds radioactive source is directly implanted into the tumor tissue, ...
Eligibility Criteria
No eligibility criteria provided.
Key Trial Info
Start Date :
June 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 28 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05421507
Start Date
June 1 2022
End Date
May 28 2026
Last Update
July 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Radiation Oncology of Peking university third hospital
Beijing, China